Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism

J Gao, K Xu, H Liu, G Liu, M Bai, C Peng… - Frontiers in cellular and …, 2018 - frontiersin.org
The gut microbiota influences the health of the host, especially with regard to gut immune
homeostasis and the intestinal immune response. In addition to serving as a nutrient …

Microbiome, inflammation and colorectal cancer

J Chen, E Pitmon, K Wang - Seminars in immunology, 2017 - Elsevier
Chronic inflammation is linked to the development of multiple cancers, including those of the
colon. Inflammation in the gut induces carcinogenic mutagenesis and promotes colorectal …

Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer

L Zhao, Y Liu, S Zhang, L Wei, H Cheng, J Wang… - Cell death & …, 2022 - nature.com
Metabolic disorders and abnormal immune function changes occur in tumor tissues and
cells to varying degrees. There is increasing evidence that reprogrammed energy …

[HTML][HTML] Kynurenine emerges from the shadows–Current knowledge on its fate and function

M Marszalek-Grabska, K Walczak, K Gawel… - Pharmacology & …, 2021 - Elsevier
Kynurenine (KYN), a main metabolite of tryptophan in mammals, is a direct precursor of
kynurenic acid, anthranilic acid and 3-hydroxykynurenine (3-HK). Under physiological …

IDO1 and kynurenine pathway metabolites activate PI3K-Akt signaling in the neoplastic colon epithelium to promote cancer cell proliferation and inhibit apoptosis

KS Bishnupuri, DM Alvarado, AN Khouri, M Shabsovich… - Cancer research, 2019 - AACR
The tryptophan-metabolizing enzyme indoleamine 2, 3 dioxygenase 1 (IDO1) is frequently
overexpressed in epithelial-derived malignancies, where it plays a recognized role in …

The footprint of kynurenine pathway in every cancer: a new target for chemotherapy

M Ala - European Journal of Pharmacology, 2021 - Elsevier
Abstract Treatment of cancers has always been a challenge for physicians. Typically,
several groups of anti-cancer medications are needed for effective management of an …

Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system

M Ala - International reviews of immunology, 2022 - Taylor & Francis
Tryptophan is an essential amino acid, going through three different metabolic pathways in
the intestines. Indole pathway in the gut microbiota, serotonin system in the enterochromaffin …

Fisetin improves hyperuricemia-induced chronic kidney disease via regulating gut microbiota-mediated tryptophan metabolism and aryl hydrocarbon receptor …

Q Ren, L Cheng, F Guo, S Tao, C Zhang… - Journal of Agricultural …, 2021 - ACS Publications
The intestinal flora serves a critical role in the development of hyperuricemia-induced
chronic kidney disease (CKD). We previously found that natural flavonol fisetin exhibited …

Targeting regulation of tryptophan metabolism for colorectal cancer therapy: a systematic review

H Zhang, A Zhang, J Miao, H Sun, G Yan, F Wu… - RSC …, 2019 - pubs.rsc.org
Colorectal cancer (CRC) is one of the most malignant cancers resulting from abnormal
metabolism alterations. As one of the essential amino acids, tryptophan has a variety of …

[HTML][HTML] Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer

XZ Sun, DY Zhao, YC Zhou, QQ Wang… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Gut tryptophan (Trp) metabolites are produced by microbiota and/or host
metabolism. Some of them have been proven to promote or inhibit colorectal cancer (CRC) …